Search by Drug Name or NDC
NDC 63323-0658-27 Chlorothiazide 500 mg/18mL Details
Chlorothiazide 500 mg/18mL
Chlorothiazide is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is CHLOROTHIAZIDE SODIUM.
Product Information
| NDC | 63323-0658 |
|---|---|
| Product ID | 63323-658_caa7f828-1628-46e2-8ee5-e90e9da681bf |
| Associated GPIs | 37600020102105 |
| GCN Sequence Number | 008171 |
| GCN Sequence Number Description | chlorothiazide sodium VIAL 500 MG INTRAVEN |
| HIC3 | R1F |
| HIC3 Description | THIAZIDE AND RELATED DIURETICS |
| GCN | 34770 |
| HICL Sequence Number | 003645 |
| HICL Sequence Number Description | CHLOROTHIAZIDE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Chlorothiazide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CHLOROTHIAZIDE SODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/18mL |
| Substance Name | CHLOROTHIAZIDE SODIUM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090896 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0658-27 (63323065827)
| NDC Package Code | 63323-658-27 |
|---|---|
| Billing NDC | 63323065827 |
| Package | 1 VIAL in 1 BOX (63323-658-27) / 18 mL in 1 VIAL |
| Marketing Start Date | 2009-10-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |